Incontinence after Prostate Treatment Flashcards

1
Q

What should clinicians should inform patients undergoing RP for CaP about continence?

A

GUIDELINE STATEMENT 1

continence could be affected

factors impact recovery:
younger age
smaller prostate size
longer membranous urethral length (MRI)

Surgical approaches do not seem to impact rates

BUT

B/L nerve sparing does (26% more likely to be continence at 6 mo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Following radical prostatectomy, what clinicians should counsel patients regarding sexual arousal and incontinence?

A

GUIDELINE STATEMENT 2

there is a risk of sexual arousal leakage (arousal, foreplay, masturbation) and climacturia (during orgasm)

can occur with RP +/- RT or RT alone

bladder contraction + external sphincter insufficiency

improves with time since surgery, can take years to resolve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What should clinicians advise regarding the duration of incontinence after RP?

A

GUIDELINE STATEMENT 3

incontinence is expected in short term and generally improves to near baseline by 12 mo after surgery but may persist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Prior to RP, patients may be offered what to help optimize ability and augment continence?

A

GUIDELINE STATEMENT 4

PFME or PFPT

easier to master before given post-op muscle inhibition, sensory changes, pain

consider therapy +/- biofeedback

3-4 weeks before surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Patients undergoing TURP or RP after RT should be informed of a high rate of?

A

GUIDELINE STATEMENT 5

Urinary incontinence

TURP → 70%

urethral fibrosis, endarteritis, decrease functional capacity of sphincter

salvage RP → 20-70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

In patients sp RP, patients should be offered this in the immediate post-op period after catheter removal?

A

GUIDELINE STATEMENT 6

PFME/PFMT

*shown to improve time to achieving continence compared to control groups in RCTs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

At what interval after prostate treatment can surgery be considered for patients with bothersome SUI?

A

GUIDELINE STATEMENT 7

as early as 6 mo

90% achieve continence by 6 mo

most patients have reached max improvement by 12 mo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

In patients with bothersome SUI after prostate treatment who failed conservative therapy should be offered what by 12 mo?

A

GUIDELINE STATEMENT 8

surgical treatment at 1 year

*restore QOL asap, will have max improvement by 12 mo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Patients should evaluate patients with SUI after prostate treatment how?

A

GUIDELINE STATEMENT 9

H&P
Appropriate diagnostic modalities
Categorize: type (SUI/UUI, MUI) , severity (pad testing), and degree of bother

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Patients with UUI or MUI, predominant urge, after prostate treatment?

A

GUIDELINE STATEMENT 10

Treat per OAB guideline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Prior to tx for SUI post prostate treatment, what should be confirmed?

A

GUIDELINE STATEMENT 11

confirm leakage with H&P and ancillary testing

SUI on exam or UDS

*every effort should be made to objectively confirm SUI prior to AUS

provocative testing, bending, shifting, rising from seated, pad test, PVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Patients with incontinence after prostate treatment should be informed of management options, including:

A

GUIDELINE STATEMENT 12

surgical and non-surgical options

(pads/clamps/catheters, PFME/PFMT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Patients with incontinence after prostate treatment should discuss risks, benefits, and expectations for what?

A

GUIDELINE STATEMENT 13

different treatment using SDM

improves patient satisfaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Prior to surgical intervention for SUI after prostate treatments what procedures may be performed in office?

A

GUIDELINE STATEMENT 14

SHOULD perform cystourethroscopy to assess urethral and bladder pathology

**stricture, BNC, lesions, sphincter, tumors

GUIDELINE STATEMENT 15

CONSIDER UDS where it may facilitate dx or counseling

*not required but may help, especially if storage issues (DO, compliance, small capacity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What first line, non-invasive treatment should be offered in men with incontinence s/p RP?

A

GUIDELINE STATEMENT 16

PFME/PFPT

*both injury to striated muscle and nerve fibers of rhabdo-spincter to lead to incontinence, support muscle strength and flow and promote healing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What surgery should be offered to patients with bothersome SUI after prostate treatment? What should be determine pre-op?

A

GUIDELINE STATEMENT 17

AUS

*risks: persistent leakage, mechanical failure, erosion, infection

GUIDELINE STATEMENT 18

adequate physical and cognitive abilities (manual dexterity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What approach is preferred for AUS implantation?

A

GUIDELINE STATEMENT 19

single cuff perineal approach

antibiotics (aminoglycoside and 1st/2nd Gen Cephalosporin, or Aztreonam and 1st/2nd Gen Cephalosporin, or Vanco/Aminoglycoside or Vanco/Aztreonam; 2nd line Amniopenicillin or Unasyn)

appropriate cuff size (introp msmt)

fill components

connect watertight

test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What may be offered to patients with mild-moderate IPT?

A

GUIDELINE STATEMENT 20

male sling

*at least 50% improvement

GUIDELINE STATEMENT 21

male slings not routinely performed for severe SUI

GUIDELINE STATEMENT 22

adjustable balloon devices may be offered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Regarding SUI after sx for BPH vs. RP, what differs?

A

GUIDELINE STATEMTN 23

NOTHING

same treatment options and indications

20
Q

For men with SUI after RT (primary, adjuvant, or salvage) seeking treatment, what is preferred?

A

GUIDELINE STATEMTN 24

AUS

preferred over sling

RT with small vessel obliteration/endarteritis → ischemic tissue change, fibrosis, necrosis → complications/erosion of sling

21
Q

What should patient with IPT be counseled about bulking agents?

A

GUIDELINE STATEMENT 25

efficacy low and cure rare

(off label, not FDA approved)

22
Q

Other potential treatments besides AUS, sling, balloon, or bulking are considered?

A

GUIDELINE STATEMENT 26

investigational

23
Q

Regarding AUS, what should patients be counseled on long term?

A

GUIDELINE STATEMENT 27

lose effectiveness over time, re-operations common

*devices can fail, any of 3 parts, micro-perforations

can explant and reimplant in same setting

*risks: device infection and erosion (hematuria, dysuria, difficulty emptying)

24
Q

Persistent or recurrent SUI after AUS or sling, clinicians should?

A

GUIDELINE STATEMENT 28

perform H&P and other investigations to determine cause

inadvertant deactivation, improper use, re-education
fluid loss → CT/US
urethral atrophy
cystoscopy

25
Q

Patients with persistent or recurrent SUI after a sling, what is recommended? After AUS?

A

GUIDELINE STATEMENT 29

AUS

GUIDELINE STATEMENT 30

revision of AUS

*suboptimal cuff sizing, proximal relocation, tandem cuff placement

26
Q

In patients with infection or erosion of AUS, what should be done?

A

GUIDELINE STATEMET 31

explantation, washout

usually urethral catheter

replacement in 3-6 mo

may need a graft to supplement the urethra (erosion risk)

27
Q

Patients after IPT treatment treatment failure and poor QOL, can be considered for?

A

GUIDELINE STATEMENT 32

Urinary diversion

*multiple device failures, intractable BNC, severe DO

Mitrofanoff, incontinent, SPT, BNC, IC

28
Q

Patients with bothersome climacturia?

A

GUIDELINE STATEMENT 33

treatment

*persistent leakage despite behavioral (empty prior to sex, condoms to catch urine, PFME)

imipramine, penile variable tension loop to coapt urethra, IPP with “tutoplast sling”, AUS, sling

29
Q

Patients with SUI after urethral reconstructive surgery may be offered? What should they be counseled?

A

GUIDELINE STATEMENT 34

AUS

higher rate of complications
*may consider transcorporal placement due to changes in urethral blood supply

30
Q

Patients with SUI and ED may be offered?

A

GUIDELINE STATEMENT 35

concomitant or staged procedures

31
Q

Patients with veiscourethral anastomotic stricture s/p RP, should have what before tx of their SUI?

A

GUIDELINE STATEMENT 36

treatment for obstruction
at least 4-6 weeks to document stabilization before SUI tx

AUS considered best in this group

32
Q

What is differential dx of IPT?

A

SUI
UUI
MUI
overflow
UTI
urethral stricture
BNC

33
Q

Objective testing for IPT at initial workup?

A

voiding diary
24 h pad test
(1 h pad test weights → Grade 1 <10g, Grade 2: 11-50 g, Grade 3: 51-100 g, Grade 4 > 100g)
emphasis on neuroexam (S2-S4) spinal segments, sphincter tone, perineal sensation, bulbocavernosus reflux
standing cough test

34
Q

After dx SUI after prostate treatment, next steps?

A
arrange cysto to r/o underlying strictures/BNC or bladder pathology
evaluate sphincter (esp if thinking sling)
35
Q

Risks for BNC after prostatectomy?

A

DM
tobacco
CAD
obesity
surgeon expertise
hemorrhage
prolonged urine leak
anastomotic disruption

**create watertight seal with good mucosal apposition

36
Q

Treatment options for BNC?

A

Dilation, success 60%
Endoscopic incision, cold knife, electrocautery, laser, hot knife, loop (risk higher SUI)

after RP (avoid 6:00 near rectum, make incision 3, 9, 12)
cath 3-7 days
37
Q

When is UDS useful in IPT?

A

equivocal when you need to asses capacity, compliance, contractility
differentiate SUI from other sxs
r/o high storage pressures
detrusor hypocontractility → AUS preferable to fixed sling resistance

38
Q

Describe surgical approach for AUS:

A
  1. Doral lithotomy
  2. Midline perineal incision: measure urethral circumference (4.0-4.5 cm for bulbar), cuff at crura just proximal to separating corporal bodies
  3. Inguinal incision for reservoir (pressure 61-70 c H20, fill with 23 c of contrast)
  4. Connect tubing
  5. Cycle sphincter
  6. Urethrosocopy to assess sphincter (closed with good coaptation, open to allow voiding)
  7. Lock cuff in open
39
Q

Contraindications to AUS?

A

impaired cognitive or manual dexterity
unresolved stricture or BNC
unresolved detrusor overactivity
existing infection

40
Q

most common complications of AUS

A

hematoma (MC)
urinary retention
persistent or recurrent incontinence
device malfunction
urethral atrophy
cuff erosion
infection

41
Q

If urethral injury during AUS?

A

abort, foley
repair injury with absorbable suture

42
Q

Workup and possibilities for persistent incontinence after AUS?

A

inadvertent deactivation

Insufficient urethral compression: mechanical failure, fluid loss, cuff erosion, bladder storage failure, urethral/bladder neck atrophy, kinked tubing

43
Q

Tender swollen scrotum and leukocytosis and UTI after AUS, dx?

A

infection of AUS/possible erosion

epididymo-orchitis
perineal cellulitis
Fournier’s

(MC staph/skin and urinary organisms)

44
Q

How do you handle an AUS erosion?

A

Remove all components
16 Fr foley across erosion for 2-4 weeks
for large defects can consider EPA
per-catheter RUG before removing foley

45
Q

Risk of urethral erosion with re-do AUS?

A

8-9%

must place proximal or distal, different location on urethra

46
Q

How do you work up recurrent SUI 5 years after AUS?

A

cycle AUS: evaluate for leakage or mechanical dysfunction

KUB to look for loss (if filled with contrast)

Cysto for poor coaptation (urethral atrophy) for erosion

smallest cuff is 3.5, so if you cannot downsize for atrophy → reposition